Rising volume to lift bulk Indian drug makers' revenue 6-8% this fiscal: Crisil
The bulk drugs segment of the Indian pharmaceutical sector is expected to see revenue grow at 6-8 per cent this fiscal year, helped by higher sales volume stemming from a stable g...